Opioid Prescribing Practices Following
Otologic and Neurotologic Surgery
Sarah Riutta, PhD1; Aaron Benson, MD2
1Advocate

Aurora Research Institute, Advocate Aurora Health; 2Department of Otolaryngology, Aurora St. Luke’s Medical Center, Advocate Aurora Health

Results

Abstract

There is no consensus on the appropriate quantity of opioids to prescribe for acute
postoperative pain. Recent publications have found the number of pills prescribed by
otolaryngologists following common ear, nose, and throat procedures varies widely
and patients typically do not consume the entirety of their prescription. This study
aims to provide insight into opioid prescribing practices at Aurora Health Care by
retrospectively examining the medical records of patients that underwent an
otologic or neurotologic surgery. Over 85% of postoperative opioid prescriptions
were written for 30 tablets of 5-325 mg hydrocodone-acetaminophen. Refills of
postoperative opioid medications were requested by 16% of patients. Our findings
suggest opioid use following surgery may be influenced by surgery type, quantity of
opioids given in the PACU, pain during PACU recovery, and patient age. A future
prospective study of patients undergoing otologic and neurotologic procedures will
be conducted to better understand how these patients use opioid pain medication to
manage postoperative pain.

Surgeons have the second highest rate of opioid prescribing among medical
specialties, accounting for nearly 37% of opioid prescriptions between 2007 and
2012.[1] The overprescribing of opioids is a topic of concern in the medical
community due to the role of opioids in drug overdose deaths. In 2018, nearly 70%
of the 67,367 reported drug overdose deaths were attributed to opioids.[2] Several
systematic reviews have identified a general trend of overprescribing of opioids
following surgical procedures, leading to an estimated 42% to 71% of postoperative
opioids remaining unused by the patient.[3,4]
Recent reports have begun to highlight prescribing practices following common ear,
nose, and throat procedures. Otologic (ear) surgeries tend to have the lowest
postoperative pain of all otolaryngologic procedures and surgeons tend to prescribe
a lower number of opioids following otologic surgery compared to other
otolaryngologic procedures.[5-7] Two recent studies by Mahairas et al. [8,9] found
otologic surgery patients were prescribed 36 pills on average per opioid script; three
other studies report otologic surgery patients use 10 pills or less, on average, to
control postoperative pain.[10-12] The evidence of opioid overprescribing following
otologic procedures warrants additional studies describing opioid prescribing and use
practices following otologic and neurotologic surgeries to supplement the sparse, but
growing, body of knowledge.

Methods

This is a retrospective medical record review study. The medical records of patients
that underwent an otologic or neurotologic surgery performed by a board-certified
neurotologist at any Aurora Health Care facility between October 1, 2018 and
August 24, 2020 were examined for inclusion. Records were excluded if the patient
was admitted to the hospital or had any other surgeries (except for Thiersch graft
procedures following tympanomastoidectomies) in the two weeks before and after
the qualifying procedure. Data extracted for this study include demographics; details
of opioid prescriptions written from 60 days prior to surgery to 28 days after
surgery; opioid, non-opioid analgesic, and corticosteroid medications given on day
of surgery; duration of surgery; and pain scores reported during PACU recovery. For
patients that were admitted for overnight observation following the qualifying
otologic/neurotologic procedure, details of opioid and non-opioid analgesics
administered during the inpatient stay were also extracted.

A total of 235 patient records met eligibility criteria. Patient demographics, surgery
types, and initial postoperative opioid prescriptions are described in Table 1. The
mean patient age was 52.2 years (range 14-93), mean BMI was 30.7 (range 18.164.7), and 55.3% of patients were female. More than half of the patients had a
procedure that included a mastoidectomy: there were 85 tympanomastoidectomies,
41 cochlear implantations, and 14 other. Procedures without a mastoidectomy
included 45 tympanoplasties, 23 stapedectomies, and 10 other. Seventeen patients
underwent BAHA implantation. All but five patients received a postoperative opioid
prescription. Eighty-five percent of patients received an initial prescription written
for 30, 5-325 mg hydrocodone-acetaminophen tablets. Patients received an average
of 152.4 morphine milligram equivalents (MME) for the initial opioid prescription.

Table 1. Patient Demographics and Opioid Prescribing Details
All Patients (n = 235)

Age in years, mean (range)

52.2 (14-93)

BMI, mean (range)

30.7 (18.1-64.7)

Female, n (%)

130 (55.3%)
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Patient demographics and surgical characteristics were investigated further to
determine if any patient or surgical factors were associated with higher rates of
opioid refill requests. Figure 1 illustrates the percentage of refill requests from
patients based on decade of age, BMI classification, PACU pain score, and surgery
type. Patients in their 40s requested refills at the highest rate of all decades at 32%
(Figure 1A). Refill request rates were similar between BMI categories; 13% of
patients with a BMI under 30 requested a refill, while 18% of patients with a BMI of
30 or higher requested a refill (Figure 1B). Patients with more postoperative pain
during PACU recovery requested refills at a higher rate. Forty-one percent of
patients rating their pain as an 8 out of 10 or higher requested a refill, compared to
just 11% of patients rating their pain as a 7 or lower (Figure 1C). Refills requests
were highest for patients that underwent a tympanomastoidectomy or BAHA
implantation: 22% of tympanomastoidectomy patients and 24% of BAHA
implantation patients requested a refill, compared to 15% of mastoidectomy
patients and 9% of non-mastoidectomy patients (Figure 1D).
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Refills of opioid pain medication were requested by 38 patients (16%). Males and
females requested refills at the same rate. Requests were made, on average, 7 days
after surgery and all requests were made within 18 days of surgery. The
characteristics of the patient cohort that requested refills and the patient cohort that
did not request refills are described in Table 2. The cohort that requested refills was
younger, reported higher pain scores during PACU recovery, and received
significantly more intravenous fentanyl and oral opioids during the perioperative
period compared to the patient cohort that did not request a refill. BMI was not
significantly different between the “refill” and “no refill” cohorts.

Table 2. Refill and No Refill Cohort Characteristics
No Refill (n = 197) P value

47.7 (13.8)

53.1 (16.9)

p < 0.05

31.7 (7.1)

30.5 (7.0)

p = 0.36

190.8 (76.5)

145.4 (82.0)

p < 0.01

PACU Oral Opioid
MME, mean (SD)

5.9 (4.6)

3.5 (4.3)

p < 0.01

Highest PACU Pain
0-10 scale, mean (SD)

6.6 (2.3)

4.3 (2.9)

p < 0.0001
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Figure 1. Refill Requests by Age, BMI, Pain Score, and Surgery Type.
Percentage of patients requesting a refill of opioid pain medication by A)
decade of age; B) BMI; C) highest pain score recorded during PACU recovery;
and D) surgery type. Black bars indicate percentage of patients that
requested a refill; grey bars represent percentage of patients that did not
request a refill; white bars indicate percentage of patients that did not receive
an initial opioid prescription for postoperative pain.

Conclusions

This retrospective study of opioid prescribing practices for otologic and neurotologic
surgery patients found over 85% of patients received the same type and quantity of
postoperative opioids, despite large variations in patient demographics and surgery
characteristics. Refills of postoperative opioid medications were requested by 16% of
patients; the patients requesting refills were significantly younger, reported
significantly higher pain scores during PACU recovery, and received significantly
more opioids during the perioperative period compared to patients that did not
request a refill. BMI does not appear to significantly impact the rate of refill
requests. Patients that underwent a tympanomastoidectomy or BAHA implantation
requested
a
refill
more
often
than
patients
that
underwent
other
otologic/neurotologic procedure types. A prospective study of otologic and
neurotologic surgery patients will be conducted in the future to collect additional
data on opioid consumption in this patient group with the goal of refining prescribing
practices to limit opioid overprescribing.

